Medswala Pharmacy India presents Apigat 2.5 mg, a pharmaceutical product containing Apixaban 2.5 mg, an oral anticoagulant belonging to the direct factor Xa inhibitor class. Apixaban helps reduce blood clot formation and is prescribed for specific clot-related conditions according to approved product labeling and medical guidance. For pharmaceutical distributors, licensed importers, and authorized procurement organizations, Apigat 2.5 mg is a product of interest within the cardiovascular and anticoagulant medicine category. Medswala Pharmacy India supports pharmaceutical sourcing enquiries and international B2B supply requirements, subject to product availability, applicable licensing, and destination-country regulations. π
π¬ Apigat 2.5 mg Product Overview
Brand Name: Apigat 2.5 mg
Generic Name: Apixaban
Strength: 2.5 mg
Dosage Form: Tablets
Manufacturer/Marketer: Natco Pharma Ltd. (verify current product packaging)
Therapeutic Category: Anticoagulant / Cardiovascular Medicine
Drug Class: Direct Factor Xa Inhibitor
Supply Enquiries: Pharmaceutical B2B sourcing and eligible export markets
Product specifications, manufacturer details, packaging, batch documentation, and market authorization should be verified before procurement.
β€οΈ What Is Apixaban 2.5 mg?
Apixaban is an anticoagulant that works by inhibiting factor Xa, a protein involved in the blood-clotting process. Depending on the approved indication and local prescribing information, apixaban may be used to reduce the risk of stroke and systemic embolism in certain adults with non-valvular atrial fibrillation, prevent blood clots after selected hip or knee replacement surgeries, or for other approved clot-related indications. The 2.5 mg strength is prescribed for specific clinical situations; it is not the appropriate dose for every patient or condition.
π Apigat 2.5 mg Supplier and Pharmaceutical Exporter from India
Medswala Pharmacy India supports enquiries for pharmaceutical products from India for eligible international markets. Buyers searching for an Apigat 2.5 mg supplier, Apixaban 2.5 mg pharmaceutical exporter, or cardiovascular medicine sourcing partner can enquire about product availability and applicable export requirements.
Our pharmaceutical B2B sourcing approach focuses on:
π International pharmaceutical supply enquiries
π¦ Product and packaging specification verification
π Applicable product and shipment documentation
π€ B2B procurement and distributor enquiries
π Shipping coordination subject to destination regulations
β Verification of relevant import permissions and product registration
Product availability, dispatch timelines, shipping options, and delivery eligibility must be confirmed for each order and destination.
π International Shipping, Delivery and Export Support
International pharmaceutical shipments require careful coordination, appropriate documentation, and compliance with the laws of the importing country.
For eligible orders, buyers may enquire about:
International pharmaceutical shipping from India
Export documentation and shipment requirements
Product availability and order processing
Estimated dispatch and delivery timelines
Country-specific import requirements
B2B pharmaceutical procurement arrangements
Worldwide delivery is subject to product authorization, import permits, applicable export rules, and confirmation of the shipment route. No delivery timeframe should be assumed until the order and destination have been verified.
π Countries and Regions for International Enquiries
Medswala Pharmacy India receives pharmaceutical supply enquiries relating to international markets, including the following countries and regions.
πΊπΈ United States
International pharmaceutical enquiries relating to New York, Los Angeles, Chicago, Houston, Dallas, Washington, Boston, Miami, San Francisco, Philadelphia, Phoenix, Denver, and other locations.
π¬π§ United Kingdom
Enquiries relating to London, Manchester, Birmingham, Leeds, Southampton, Cardiff, Belfast, Newcastle, and other locations.
π¦πΊ Australia
Enquiries relating to Sydney, Melbourne, Brisbane, Perth, Adelaide, Gold Coast, Townsville, and other locations.
πΈπ¬ Singapore
Enquiries relating to Singapore, including Ang Mo Kio, Serangoon, and Pasir Ris.
π Other International Markets
Enquiries may also relate to Japan, Chile, South Korea, Thailand, and the Philippines. These are potential international enquiry markets, not a guarantee that Apigat 2.5 mg is approved, registered, or available for shipment to every listed destination. Local medicine registration, prescription-drug import rules, and importer authorization must be confirmed before supply.
π Why Choose Medswala Pharmacy India for Pharmaceutical Enquiries?
Medswala Pharmacy India aims to connect international pharmaceutical buyers with product sourcing and export support from India.
Our B2B enquiry process can cover:
Pharmaceutical product availability
Manufacturer and product information
Packaging and batch documentation
International procurement requirements
Export eligibility and shipment coordination
Destination-specific regulatory checks
All orders are subject to verification, availability, relevant licences, and applicable pharmaceutical regulations.
π© Apigat 2.5 mg β International B2B Product Enquiries
Looking for information about Apigat 2.5 mg Apixaban Tablets for a legitimate pharmaceutical procurement requirement?
Contact Medswala Pharmacy India to enquire about product specifications, availability, documentation, and eligible export destinations.
Medswala Pharmacy India β Global Pharmaceutical Exporter from India
π International Pharmaceutical Supply Enquiries | B2B Sourcing | Export Documentation Support
Contact & Business Details
π± WhatsApp: +91-9359256675 (π₯ Best Offer β Order on WhatsApp & Save More! π₯)
π¬ WhatsApp Link : https://wa.me/+919359256675
π§ Email: sales@medswalapharmacy.com
π Website: https://www.indiamedicineexporter.com/